Dano actively seeks strategic partnerships to accelerate impact — from R&D alliances to global distribution and contract manufacturing.
Whether you are a procurement agency, a biopharma company, or a research institution, Dano has a structured engagement model for your needs.
Supply partnerships for national immunisation programmes, institutional procurement, and private market distribution — domestically in India and across international ROW tender markets.
End-to-end contract manufacturing and fill-finish solutions for biological products, leveraging our integrated DS+DP infrastructure, automated aseptic lines, and validated QMS.
In-licensing and technology transfer for novel biological products targeting commercialisation within India and other emerging markets. Our technical team manages the full transfer lifecycle.
Collaborative R&D with academic institutions, government bodies, and global health organisations to co-develop new immunological and biological solutions for underserved populations.
Our partners choose Dano because of a proven track record, integrated infrastructure, and the regulatory standing to supply global markets confidently.
Aligned with global expectations for quality, safety, and efficacy in vaccine production.
Certified quality system covering all manufacturing and QC functions across the lifecycle.
Compliant with Indian Schedule M and international GMP standards for data integrity.
Drug Substance and Drug Product under one roof, providing end-to-end control and oversight.
Multi-market product registrations and facility approvals across key Asia and Africa markets.
Located in India's vaccine capital — providing access to a robust talent and supply chain ecosystem.